These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Development and design validation of a novel network meta-analysis presentation tool for multiple outcomes: a qualitative descriptive study. Phillips MR; Sadeghirad B; Busse JW; Brignardello-Petersen R; Cuello-Garcia CA; Kenji Nampo F; Guo YJ; Bzovsky S; Bannuru RR; Thabane L; Bhandari M; Guyatt GH BMJ Open; 2022 Jun; 12(6):e056400. PubMed ID: 35688599 [TBL] [Abstract][Full Text] [Related]
29. Identifying inconsistency in network meta-analysis: Is the net heat plot a reliable method? Freeman SC; Fisher D; White IR; Auperin A; Carpenter JR Stat Med; 2019 Dec; 38(29):5547-5564. PubMed ID: 31647136 [TBL] [Abstract][Full Text] [Related]
30. Visualizing inconsistency in network meta-analysis by independent path decomposition. Krahn U; Binder H; König J BMC Med Res Methodol; 2014 Dec; 14():131. PubMed ID: 25510877 [TBL] [Abstract][Full Text] [Related]
31. Graphical tools for network meta-analysis in STATA. Chaimani A; Higgins JP; Mavridis D; Spyridonos P; Salanti G PLoS One; 2013; 8(10):e76654. PubMed ID: 24098547 [TBL] [Abstract][Full Text] [Related]
32. Uncertainty in Treatment Rankings: Reanalysis of Network Meta-analyses of Randomized Trials. Trinquart L; Attiche N; Bafeta A; Porcher R; Ravaud P Ann Intern Med; 2016 May; 164(10):666-73. PubMed ID: 27089537 [TBL] [Abstract][Full Text] [Related]
33. Considering multiple outcomes with different weights informed the hierarchy of interventions in network meta-analysis. Mavridis D; Nikolakopoulou A; Moustaki I; Chaimani A; Porcher R; Boutron I; Ravaud P J Clin Epidemiol; 2023 Feb; 154():188-196. PubMed ID: 36581305 [TBL] [Abstract][Full Text] [Related]
34. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Jansen JP; Fleurence R; Devine B; Itzler R; Barrett A; Hawkins N; Lee K; Boersma C; Annemans L; Cappelleri JC Value Health; 2011 Jun; 14(4):417-28. PubMed ID: 21669366 [TBL] [Abstract][Full Text] [Related]
35. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. Hoaglin DC; Hawkins N; Jansen JP; Scott DA; Itzler R; Cappelleri JC; Boersma C; Thompson D; Larholt KM; Diaz M; Barrett A Value Health; 2011 Jun; 14(4):429-37. PubMed ID: 21669367 [TBL] [Abstract][Full Text] [Related]
36. Network Meta-analysis: Users' Guide for Surgeons: Part I - Credibility. Foote CJ; Chaudhry H; Bhandari M; Thabane L; Furukawa TA; Petrisor B; Guyatt G Clin Orthop Relat Res; 2015 Jul; 473(7):2166-71. PubMed ID: 25869061 [TBL] [Abstract][Full Text] [Related]
37. The pits and falls of graphical presentation. Sperandei S Biochem Med (Zagreb); 2014; 24(3):311-20. PubMed ID: 25351349 [TBL] [Abstract][Full Text] [Related]
38. Network meta-analysis results against a fictional treatment of average performance: Treatment effects and ranking metric. Nikolakopoulou A; Mavridis D; Chiocchia V; Papakonstantinou T; Furukawa TA; Salanti G Res Synth Methods; 2021 Mar; 12(2):161-175. PubMed ID: 33070439 [TBL] [Abstract][Full Text] [Related]
39. First-line treatments for chronic lymphocytic leukaemia: interpreting efficacy data by network meta-analysis. Messori A; Fadda V; Maratea D; Trippoli S Ann Hematol; 2015 Jun; 94(6):1003-9. PubMed ID: 25677267 [TBL] [Abstract][Full Text] [Related]